Physical activity as an aid for smoking cessation

Similar documents
Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health

Prévention et promotion de la santé

Supplementary Online Content

Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes

Smoking cessation and weight gain

Table S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).

A randomized trial comparing two Internetbased smoking cessation programs

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence

Cardiovascular Risk Assessment and Management Making a Difference

Module 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension

To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.

Risk Factors for Heart Disease

Depok-Indonesia STEPS Survey 2003

4. resisted training ** OR resistance training * OR resisted exercise ** OR resistance exercise ** OR strength training ** OR strength exercise **

Metabolic Syndrome and Workplace Outcome

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

ASSeSSing the risk of fatal cardiovascular disease

Cardiovascular Disease Risk Factors:

A multicenter tobacco cessation program in acute coronary syndrome

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution

Know Your Number Aggregate Report Single Analysis Compared to National Averages

(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects

2 nd European Harm Reduction Conference session. Tobacco and Harm Reduction. Prof. Jacques Cornuz, Policlinique Médicale Universitaire, Lausanne

ADHD and Adverse Health Outcomes in Adults

Adult Pre Participation Screening and Exercise Prescription Practicum

CVD Prevention, Who to Consider

Biases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University

Diabetes risk scores and death: predictability and practicability in two different populations

Epidemiology and Prevention

the high CVD risk smoker

PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN

Smoking and Smoking Cessation in England 2011: Findings from the Smoking Toolkit Study

Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden

Diabetes Mellitus: A Cardiovascular Disease

Body-mass index and cause-specific mortality in adults: collaborative analyses of 57 prospective studies

Hospital Authority Convention 2010 Presented by : Dr Cheng Ming Kin Medical Officer,Department of Medicine Tseung Kwan O Hospital

ESPEN Congress Florence 2008

Vascular Diseases. Overview: Selected Slides

Randomized controlled trial of physical activity counseling as an aid to smoking cessation: 12 month follow-up

Pharmacologic Therapy for Tobacco Use & Dependence

Perceived relative harm of e cigarettes and attitudes towards their availability, advertising and use: A longitudinal survey

Integrating Tobacco Cessation into Practice

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY

ΑΡΑΠΟΓΙΑΝΝΗ ΑΘΗΝΑ Αναπληρώτρια Διευθύντρια Γ Καρδιολογικής Κλινικής Ευρωκλινικής Αθηνών

Effect of Smoking, Alcohol and Exercise on the Prevalence of Metabolic Syndrome in a Cohort of Royal Jordanian Air Pilots

SMOKING CESSATION EFFECTS ON BODY WEIGHT, HAEMOGLOBIN, TOTAL AND HDL CHOLESTEROL AND BLOOD PRESSURE

What Do We Know About Best Practice Prenatal Counseling Interventions In Clinical Settings?

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC)

CHAPTER IV RESEARCH METHOD. This study belongs to the field of Internal Medicine, specifically the field

Case Study: Chris Arden. Peripheral Arterial Disease

Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.

David Wright, MD Speaking of Women s Health Shawnee Mission Medical Center October 4, 2013

LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME

Smoking Cessation within tobacco control: Own contributions

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

Relationship of insulin resistance with Lipid profile markers in cigarette smoker

Executive Summary Report Sample Executive Report Page 1

Clinical Recommendations: Patients with Periodontitis

Models of preventive care in clinical practice to achieve 25 by 25

THE EFFECT OF SECONDHAND SMOKE EXPOSURE ON HIGH MOLECULAR WEIGHT ADIPONECTIN LEVELS IN ADULT WOMEN: A PRELIMINARY REPORT

Pharmacotherapy for Tobacco Dependence Treatment

Supplementary Online Content

The Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk

HEALTH TARGETS IN PRIMARY CARE

115 remained abstinent. 140 remained abstinent. Relapsed Remained abstinent Total

Diagnostic Test of Fat Location Indices and BMI for Detecting Markers of Metabolic Syndrome in Children

EXS 145 Guidelines for Exercise Testing & Prescription

Smoking Cessation Strategies in 2017

Treatment Outcomes of a Tailored Smoking Cessation Programme for Individuals Accessing Addiction Treatment Services

The role of physical activity in the prevention and management of hypertension and obesity

Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions

Sleep Problems and Smoking Cessation in Women

Journal of the American College of Cardiology Vol. 48, No. 2, by the American College of Cardiology Foundation ISSN /06/$32.

ADULT PRE-EXERCISE SCREENING TOOL

Breaking the Chains of Nicotine Dependence - A Breakthrough Approach

Association of Current and Past Smoking with Metabolic Syndrome in Men

Attendee become familiar with the evidence for the major risk factors for CVD Attendee will become familiar with the

SMOKING & DIABETES. Smoke signals E NRT Diabetes S08.indd 1 6/11/15 10:

Smoking Cessation in Pregnancy. Jessica Reader, MD, MPH Family Medicine Obstetrics Fellow June 1st, 2018

Nicotine Replacement Therapy and Brief Motivational Interview for Emergency Department Smokers with Asthma

Pharmacotherapy Safety and Efficacy in Adolescent Smoking Cessation

Preventing Child and Adolescent Smoking

CVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic

Introduction to pharmacotherapy

SIGN 149 Risk estimation and the prevention of cardiovascular disease. Quick Reference Guide July Evidence

Physical Health Checks

ADENIYI MOFOLUWAKE MPH APPLIED EPIDEMIOLOGY WEEK 5 CASE STUDY ASSIGNMENT APRIL

Trends in electronic cigarette use in England

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

The Vancouver General Hospital Smoking Cessation Clinic: Outcomes from a Specialist Cessation Service within Cardiology

Obesity and Smoking: Comparing Cessation Treatment Seekers With the General Smoking Population

2016 EUROPEAN GUIDELINES ON CVD PREVENTION IN CLINICAL PRACTICE

SAFETY E-CIGS: CLINICAL STUDIES

Andrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University

Is socioeconomic position related to the prevalence of metabolic syndrome? Influence of

Diabetes and Cardiovascular Risk Management Denise M. Kolanczyk, PharmD, BCPS-AQ Cardiology

Clearing the Air: What You Need to Know and Do to Prepare to Quit Smoking. Getting Ready to Quit Course

Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Transcription:

Physical activity as an aid for smoking cessation - study David Faeh, MD Christiane Ruffieux, PhD Jacques Cornuz, MD, MPH Background Prevalence of smoking in Switzerland: 33% Most smokers cumulate both risk behaviors, i.e., smoking and sedentarity. Prevalence of sedentary lifestyle is higher among smokers than non smokers. Levels of physical activity inversely related to smoking rates 1

Gradient of sedentary lifestyle among Swiss smokers (2002) Women Men 60% 60% 40% 40% 20% 20% 0% 0% smokers Nonsmokers Exsmokers 1-9 cig/d 10-19 cig/d 20 cig/d Nonsmokers Ex- 1-9 cig/d 10-19 cig/d 20 cig/d 15-39 y 40-64 y 65 y or more Working Hypothesis Including a tailored moderate-intensity physical activity it intervention ti in a standard d smoking cessation treatment program (pharmaceutical treatment and counseling) increases the chances of quitting and reduces nicotine withdrawal symptoms, negative moods, perceived stress, and weight gain. 2

Specific aims Main objective: to determine whether a tailored physical activity intervention involving moderate- intensity exercise is an added value to a standard smoking cessation intervention in term of likelihood of smoking abstinence. Secondary objectives to determine whether this intervention prevents weight gain, reduces withdrawal symptoms, stress and improve mood and self-confidence in quitting to assess the effect of this intervention on lipids profil, body composition and leptin concentration. Methods Randomized controlled trial of 560 sedentary adults regular smokers recruited from the community (lay press) (Cochrane library) Allocated into one of the two groups (intervention group vs. control group) during a 10-week period and 2 follow-up visits (6, 12 months follow-up). All subjects (intervention and control groups) participate in a smoking cessation program composed of a pharmacological treatment (nicotine replacement therapy: patch and/or an inhaler) and individual counseling (Onkologie 2002, Annals Intern Med 2002). 3

Intervention The intervention group will attend the 10- week physical activity it program blending moderate-intensity exercise and lifestyle physical activity and the control group a 10-week health education program to ensure equal contact condition. Study population: Inclusion criteria Current daily smoker >10 or more cigarettes per day Having smoked (on average > 10 cigarettes/day) regularly for at least 3 years Age between 18 and 65 years Sedentary lifestyle defined as less than 20 minutes a day of moderate-intensity t it physical assessed by the Swiss Baseline Questionnaire. 4

Exclusion criteria Current pharmacological agent use to quit smoking Medical problems that would alter training responses (arthritis, orthopedic problems) Presence of an unstable medical condition Current or recent major cardiovascular event Current psychiatric illness, substance abuse Current or planned pregnancy Systematic skin disease Preliminary analysis: AIMS 1. To compare Cardiovascular Disease Risk (CVD-risk) profile between heavy smokers and regular smokers 2. To examine the hypothesis that CVD-risk is associated with number of daily smoked cigarettes 3. To asses the impact of waist circumference on CVD-risk in heavy smokers 5

Criteria for being at risk for cardiovascular disease (CVD)* 1. Triglycerides 2.0 mmol/l 2. LDL-cholesterol 4.0 mmol/l 3. HDL-cholesterol 1.0 mmol/l 4. Mean blood pressure** 100 mm Hg Definition iti for being at risk for CVD: When meeting 2 or more criteria * European Group for the Study of Insulin Resistance (EGIR). Diabet Med 1999;16:442 3. ** DBP+((SBP-DBP)/3) Definition of heavy smokers heavy smokers = upper tertile of number of daily smoked cigarettes Only data of first 215 male smokers here presented 6

Participants characteristics Mean (± SD) age: 42.2 years (± 9.4) Mean (± SD) number of daily smoked cig.: 29.4 (± 112) 11.2 67 (31%) heavy smokers: 35 to 70 cigarettes Mean (± SD) Fagerström score: 5.8 (± 2.3) Mean previous quit attempts: 2.8 92 (43%) at CVD-risk Mean (± SD) BMI: 25.0 kg/m2 (± 36) 3.6) Mean waist circ. (± SD): 87.5 cm (± 9.8) CVD-risk by categories of daily smoked cigarettes 52%.5 mean CVD-risk.1.2.3.4 38% 0 10-30 35-70 number of daily smoked cigarettes Chi2 p-value 0.06 7

CVD-risk by categories of daily smoked cigarettes 52% mean CVD-risk.2.3.4.5 34% 42% 0.1 10-22 22.5-30 35-70 number of daily smoked cigarettes Age of heavy smokers versus regular smokers 2 age years 20 30 40 50 60 10-30 35-70 number of daily smoked cigarettes T-test p-value: 0.02 8

BMI of heavy smokers versus regular smokers 15 bmi kgm2 5 20 25 30 35 10-30 35-70 number of daily smoked cigarettes T-test pvalue 0.05 Waist circumference of heavy smokers versus regular smokers 60 waist circumference 0 80 100 120 10-30 35-70 number of daily smoked cigarettes T-test pvalue 0.002 9

CVD-risk profil by waist circumference and number of smoked cigarettes.8 mean CVD-risk 0.2.4.6 24%* 30%** 57%*** nb cig 10-30 35-70 10-30 35-70 waist circ 68-87 87.5-115 66%**** *CI [15-35%] **CI [13-50%] ***CI [44-69%] ****CI [49-80%] The stratification for waist circumference strongly attenuates the association between being a heavy smoker and at risk for CVD (not statistically sign.) Odds Ratio for CVD-risk* HND smokers vs. Regular smokers adjustment 95% CI N no adj 1.74 0.97-3.12 215 adj for age 1.46 0.79-2.70 215 adj for BMI 1.44 0.77-2.70 211 adj for waist circ. 1.19 0.62-2.30 211 adj for BMI & waist 1.18 0.61-2.27 211 adj for Age, waist &BMI 1.06 0.54-2.09 211 *CVD-risk = dependent variable, independent variable = number of daily smoked cigarettes and cotinine respectively 10

Limitations Cross-sectional data Surrogate dependant variable (CVD-risk) Only men Conclusions In male smokers, association of being heavy smoker and being at risk for CVD was close to significance (p=0.06). Thus, even among smokers, CVD-risk appears to increase with number of cigarettes After adjustment for waist circumference, BMI and age, associations diminished and were not significant anymore 11

Conclusions Adjustment of waist circumference had a stronger impact on CVD-risk of heavy smokers than adjustment for BMI and age. This result supports the hypothesis that CVDrisk of heavy smokers might be mediated by waist circumference. Other studies show, that smoking changes body composition by increasing visceral adipose tissue and that increased waist circumference may mediate CVD-risk of smokers * *Bigaard et al, 2003, Obes Res; Bamia et al, 2004, Int J Obes Relat Metab Disord Acknowledgements R. Bize, MD R. Stoianov, RN B. Marti, MD MPH L. Tappy, MD F. Paccaud, MD V. Girardet, «allez-hop» J.-L. Gilliéron, Lausanne University it Sports center And all others health care professionals involved in the study 12